Steris Plc Financials
This page shows Steris Plc (STE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
STERIS’s recent results show a cash-generating deleveraging cycle, with stable gross economics funding balance-sheet repair.
A broadly flat gross margin paired with operating cash flow rising from$757M to$1.15B says the recent improvement came less from richer product economics and more from converting similar economics into cash with less drag. That stronger cash conversion then helped cut long-term debt from$3.12B to$1.92B while dividends and buybacks continued.
The biggest earnings swings happened while gross margin stayed in a narrow band, so the volatility sat mostly below the gross-profit line. That points more to shifts in overhead, financing, or one-time items than to a weakening in the company’s basic selling-cost spread.
The balance sheet still looks acquisition-built: goodwill is
Financial Health Signals
Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Steris Plc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Steris Plc has an operating margin of 36.0%, meaning the company retains $36 of operating profit per $100 of revenue. This strong profitability earns a score of 80/100, reflecting efficient cost management and pricing power. This is up from 15.9% the prior year.
Steris Plc's revenue declined 43.9% year-over-year, from $5.5B to $3.1B. This contraction results in a growth score of 0/100.
Steris Plc carries a low D/E ratio of 0.25, meaning only $0.25 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.
Steris Plc's current ratio of 2.09 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.
Steris Plc converts 31.8% of revenue into free cash flow ($972.4M). This strong cash generation earns a score of 81/100.
Steris Plc's ROE of 10.9% shows moderate profitability relative to equity, earning a score of 32/100. This is up from 9.3% the prior year.
Steris Plc scores 4.65, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($20.6B) relative to total liabilities ($3.5B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Steris Plc passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Steris Plc generates $1.71 in operating cash flow ($1.3B OCF vs $782.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Steris Plc earns $18.2 in operating income for every $1 of interest expense ($1.1B vs $60.7M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Steris Plc generated $3.1B in revenue in fiscal year 2026. This represents a decrease of 43.9% from the prior year.
Steris Plc's EBITDA was $1.6B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 18.3% from the prior year.
Steris Plc reported $782.3M in net income in fiscal year 2026. This represents an increase of 27.3% from the prior year.
Steris Plc earned $7.93 per diluted share (EPS) in fiscal year 2026. This represents an increase of 27.9% from the prior year.
Cash & Balance Sheet
Steris Plc generated $972.4M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 25.0% from the prior year.
Steris Plc held $439.6M in cash against $1.8B in long-term debt as of fiscal year 2026.
Steris Plc paid $2.46 per share in dividends in fiscal year 2026. This represents an increase of 10.3% from the prior year.
Steris Plc had 98M shares outstanding in fiscal year 2026. This represents a decrease of 0.7% from the prior year.
Margins & Returns
Steris Plc's gross margin was 85.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 41.8 percentage points from the prior year.
Steris Plc's operating margin was 36.0% in fiscal year 2026, reflecting core business profitability. This is up 20.1 percentage points from the prior year.
Steris Plc's net profit margin was 25.6% in fiscal year 2026, showing the share of revenue converted to profit. This is up 14.3 percentage points from the prior year.
Steris Plc's ROE was 10.9% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 1.6 percentage points from the prior year.
Capital Allocation
Steris Plc invested $112.9M in research and development in fiscal year 2026. This represents an increase of 4.9% from the prior year.
Steris Plc spent $235.5M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 11.4% from the prior year.
Steris Plc invested $369.0M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 0.3% from the prior year.
STE Income Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B+2.5% | $1.5B+5.0% | $1.4B-6.0% | $1.5B+8.0% | $1.4B+3.1% | $1.3B+3.9% | $1.3B-9.9% | $1.4B |
| Cost of Revenue | $840.7M+3.2% | $814.4M+6.7% | $763.1M-9.1% | $839.4M+10.4% | $760.2M+1.3% | $750.1M+6.1% | $707.1M-15.5% | $836.5M |
| Gross Profit | $655.5M+1.5% | $645.9M+2.9% | $628.0M-2.1% | $641.3M+5.1% | $610.3M+5.4% | $578.8M+1.1% | $572.4M-1.8% | $582.9M |
| R&D Expenses | $29.5M+4.6% | $28.2M+6.8% | $26.4M-4.5% | $27.6M+0.9% | $27.4M+1.5% | $27.0M+5.5% | $25.6M | N/A |
| SG&A Expenses | $352.3M+0.7% | $349.7M-1.2% | $353.8M+6.0% | $333.9M-0.5% | $335.5M+1.9% | $329.3M-1.9% | $335.6M | N/A |
| Operating Income | $273.2M+2.8% | $265.8M+8.0% | $246.0M+13.8% | $216.1M-11.9% | $245.3M+11.7% | $219.7M+18.4% | $185.5M | N/A |
| Interest Expense | $14.9M0.0% | $14.9M-6.3% | $15.9M-6.9% | $17.1M-10.6% | $19.1M-3.0% | $19.7M-35.2% | $30.4M | N/A |
| Income Tax | $63.5M+4.8% | $60.6M+12.4% | $53.9M+6.8% | $50.5M-8.9% | $55.4M+27.4% | $43.5M+23.2% | $35.3M-5.3% | $37.3M |
| Net Income | $192.9M+0.5% | $191.9M+8.2% | $177.4M+21.7% | $145.7M-16.0% | $173.5M+15.7% | $150.0M+3.2% | $145.4M+10659.2% | -$1.4M |
| EPS (Diluted) | $1.96+1.0% | $1.94+8.4% | $1.79 | N/A | $1.75+15.9% | $1.51+3.4% | $1.46+14700.0% | $-0.01 |
STE Balance Sheet
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.6B+1.7% | $10.4B+0.1% | $10.4B+2.5% | $10.1B+1.4% | $10.0B-2.3% | $10.2B+1.3% | $10.1B-8.6% | $11.1B |
| Current Assets | $2.3B+8.5% | $2.1B+2.4% | $2.1B+2.8% | $2.0B+5.4% | $1.9B-2.1% | $1.9B-0.1% | $1.9B-32.4% | $2.9B |
| Cash & Equivalents | $423.7M+32.7% | $319.2M+14.1% | $279.7M+62.9% | $171.7M+10.6% | $155.2M-9.9% | $172.2M-13.2% | $198.3M-4.2% | $207.0M |
| Inventory | $673.5M+2.3% | $658.5M+2.7% | $641.2M+10.3% | $581.3M-10.5% | $649.6M-5.7% | $688.9M-1.4% | $698.6M+3.6% | $674.5M |
| Accounts Receivable | $990.6M+4.6% | $947.3M0.0% | $947.1M-9.3% | $1.0B+14.1% | $915.2M-0.9% | $923.3M+3.4% | $892.6M-11.5% | $1.0B |
| Goodwill | $4.2B+0.4% | $4.2B-0.2% | $4.2B+3.1% | $4.1B+1.3% | $4.0B-2.6% | $4.2B+2.3% | $4.1B-0.3% | $4.1B |
| Total Liabilities | $3.4B+1.0% | $3.4B-1.4% | $3.4B-2.7% | $3.5B-1.4% | $3.6B-1.4% | $3.6B-2.8% | $3.7B-21.3% | $4.7B |
| Current Liabilities | $922.3M+3.8% | $888.9M-4.1% | $926.6M-9.4% | $1.0B+14.7% | $891.1M+10.6% | $805.5M-3.5% | $834.4M-10.4% | $931.1M |
| Long-Term Debt | $1.9B+0.1% | $1.9B-0.3% | $1.9B-0.8% | $1.9B-5.9% | $2.0B-5.4% | $2.2B-3.6% | $2.2B-28.3% | $3.1B |
| Total Equity | $7.2B+2.1% | $7.0B+0.7% | $7.0B+5.4% | $6.6B+2.9% | $6.4B-2.7% | $6.6B+3.8% | $6.4B+0.8% | $6.3B |
| Retained Earnings | $2.9B+4.8% | $2.7B+5.0% | $2.6B+4.9% | $2.5B+3.8% | $2.4B+5.2% | $2.3B+4.1% | $2.2B+4.3% | $2.1B |
STE Cash Flow Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $298.2M+3.6% | $287.8M-31.5% | $420.0M+61.1% | $260.8M-21.6% | $332.8M+32.7% | $250.8M-17.4% | $303.7M+19.2% | $254.8M |
| Capital Expenditures | $98.7M+14.1% | $86.5M-7.6% | $93.6M+32.0% | $70.9M-20.5% | $89.2M-12.5% | $101.9M-5.7% | $108.1M+18.1% | $91.5M |
| Free Cash Flow | $199.5M-0.9% | $201.3M-38.3% | $326.4M+71.9% | $189.9M-22.0% | $243.6M+63.6% | $148.9M-23.9% | $195.6M+19.8% | $163.3M |
| Investing Cash Flow | -$98.5M-11.6% | -$88.3M+18.6% | -$108.5M-55.4% | -$69.8M+43.6% | -$123.9M-17.7% | -$105.3M-115.3% | $687.8M+819.4% | -$95.6M |
| Financing Cash Flow | -$98.0M+38.4% | -$159.2M+25.3% | -$213.1M-19.7% | -$178.1M+16.9% | -$214.4M-18.5% | -$181.0M+81.9% | -$998.9M-594.8% | -$143.8M |
| Dividends Paid | $61.9M0.0% | $61.9M+10.1% | $56.2M+0.4% | $56.0M-0.4% | $56.2M-0.2% | $56.3M+9.5% | $51.4M0.0% | $51.4M |
| Share Buybacks | $50.1M-50.1% | $100.5M+848.1% | $10.6M+4696.4% | $221K-99.8% | $100.5M+116.5% | $46.4M-27.7% | $64.2M+19653.8% | $325K |
STE Financial Ratios
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.8%-0.4pp | 44.2%-0.9pp | 45.1%+1.8pp | 43.3%-1.2pp | 44.5%+1.0pp | 43.5%-1.2pp | 44.7%+3.7pp | 41.1% |
| Operating Margin | 18.3%+0.1pp | 18.2%+0.5pp | 17.7%+3.1pp | 14.6%-3.3pp | 17.9%+1.4pp | 16.5%+2.0pp | 14.5% | N/A |
| Net Margin | 12.9%-0.3pp | 13.1%+0.4pp | 12.8%+2.9pp | 9.8%-2.8pp | 12.7%+1.4pp | 11.3%-0.1pp | 11.4%+11.5pp | -0.1% |
| Return on Equity | 2.7%-0.0pp | 2.7%+0.2pp | 2.5%+0.3pp | 2.2%-0.5pp | 2.7%+0.4pp | 2.3%-0.0pp | 2.3%+2.3pp | -0.0% |
| Return on Assets | 1.8%-0.0pp | 1.8%+0.1pp | 1.7%+0.3pp | 1.4%-0.3pp | 1.7%+0.3pp | 1.5%+0.0pp | 1.4%+1.4pp | -0.0% |
| Current Ratio | 2.48+0.1 | 2.37+0.1 | 2.22+0.3 | 1.96-0.2 | 2.13-0.3 | 2.41+0.1 | 2.33-0.8 | 3.08 |
| Debt-to-Equity | 0.270.0 | 0.270.0 | 0.27-0.0 | 0.29-0.0 | 0.320.0 | 0.33-0.0 | 0.35-0.1 | 0.50 |
| FCF Margin | 13.3%-0.5pp | 13.8%-9.7pp | 23.5%+10.6pp | 12.8%-4.9pp | 17.8%+6.6pp | 11.2%-4.1pp | 15.3%+3.8pp | 11.5% |
Similar Companies
Frequently Asked Questions
What is Steris Plc's annual revenue?
Steris Plc (STE) reported $3.1B in total revenue for fiscal year 2026. This represents a -43.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Steris Plc's revenue growing?
Steris Plc (STE) revenue declined by 43.9% year-over-year, from $5.5B to $3.1B in fiscal year 2026.
Is Steris Plc profitable?
Yes, Steris Plc (STE) reported a net income of $782.3M in fiscal year 2026, with a net profit margin of 25.6%.
What is Steris Plc's EBITDA?
Steris Plc (STE) had EBITDA of $1.6B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Steris Plc have?
As of fiscal year 2026, Steris Plc (STE) had $439.6M in cash and equivalents against $1.8B in long-term debt.
What is Steris Plc's gross margin?
Steris Plc (STE) had a gross margin of 85.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Steris Plc's operating margin?
Steris Plc (STE) had an operating margin of 36.0% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Steris Plc's net profit margin?
Steris Plc (STE) had a net profit margin of 25.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Does Steris Plc pay dividends?
Yes, Steris Plc (STE) paid $2.46 per share in dividends during fiscal year 2026.
What is Steris Plc's return on equity (ROE)?
Steris Plc (STE) has a return on equity of 10.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Steris Plc's free cash flow?
Steris Plc (STE) generated $972.4M in free cash flow during fiscal year 2026. This represents a 25.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Steris Plc's operating cash flow?
Steris Plc (STE) generated $1.3B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Steris Plc's total assets?
Steris Plc (STE) had $10.7B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Steris Plc's capital expenditures?
Steris Plc (STE) invested $369.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Steris Plc spend on research and development?
Steris Plc (STE) invested $112.9M in research and development during fiscal year 2026.
What is Steris Plc's current ratio?
Steris Plc (STE) had a current ratio of 2.09 as of fiscal year 2026, which is generally considered healthy.
What is Steris Plc's debt-to-equity ratio?
Steris Plc (STE) had a debt-to-equity ratio of 0.25 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Steris Plc's return on assets (ROA)?
Steris Plc (STE) had a return on assets of 7.3% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Steris Plc's Altman Z-Score?
Steris Plc (STE) has an Altman Z-Score of 4.65, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Steris Plc's Piotroski F-Score?
Steris Plc (STE) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Steris Plc's earnings high quality?
Steris Plc (STE) has an earnings quality ratio of 1.71x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Steris Plc cover its interest payments?
Steris Plc (STE) has an interest coverage ratio of 18.2x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Steris Plc?
Steris Plc (STE) scores 55 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.